Overview
Inhalation aerosols continue to be the basis for successful lung therapy for several diseases, with therapeutic strategies and the range of technology significantly evolving in recent years. In response, this third edition takes a new approach to reflect the close integration of technology with its application. After briefly presenting the general considerations that apply to aerosol inhalation, the central section of the book uses the focus on disease and therapeutic agents to illustrate the application of specific technologies. The final integrated strategies section draws the major points from the applications for disease targets and drug products.
Full Product Details
Author: Anthony J. Hickey (RTI International, North Carolina, USA) ,
Heidi M. Mansour
Publisher: Taylor & Francis Ltd
Imprint: CRC Press
Edition: 3rd edition
Weight: 0.810kg
ISBN: 9780367731489
ISBN 10: 0367731487
Pages: 417
Publication Date: 18 December 2020
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Paperback
Publisher's Status: Active
Availability: In Print
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.
Reviews
This is a comprehensive resource for understanding the fundamentals of inhalation drug development and their use in a variety of lung diseases.This updated edition is likely justified due to the expansion in the technology and development of inhalation drugs in the market. Santosh Dhungana, MD(Temple University Lewis Katz School of Medicine)
"""This is a comprehensive resource for understanding the fundamentals of inhalation drug development and their use in a variety of lung diseases.This updated edition is likely justified due to the expansion in the technology and development of inhalation drugs in the market."" Santosh Dhungana, MD(Temple University Lewis Katz School of Medicine) ""This is a comprehensive resource for understanding the fundamentals of inhalation drug development and their use in a variety of lung diseases.This updated edition is likely justified due to the expansion in the technology and development of inhalation drugs in the market."" Santosh Dhungana, MD(Temple University Lewis Katz School of Medicine) This book provides a comprehensive review of the aerosol technology literature by separating the text into 3 separate sections. The first section has 7 chapters and evaluates the physiology of aerosol therapy. The second section focuses on the use of aerosol technology in speci!c lung diseases, with 16 chapters focusing on topics including neonatal and pediatric inhalational drug delivery, asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and a chapter exploring nasal drug delivery. The third section is composed of 4 chapters and focuses on integrating strategies, leveraging the information gained from the first 2 sections, exploring such topics as factors affecting lung deposition and future developments in inhalational therapy. This book is extremely well written and referenced with a very logical and concise approach to rich literature, and is a a great resource for clinicians and academicians with an interest in optimizing inhalational therapy. John J. Oppenheimer, MD, FACAAI University of Medicine and Dentistry of New Jersey Newark, New Jersey"
This is a comprehensive resource for understanding the fundamentals of inhalation drug development and their use in a variety of lung diseases.This updated edition is likely justified due to the expansion in the technology and development of inhalation drugs in the market. Santosh Dhungana, MD(Temple University Lewis Katz School of Medicine) This book provides a comprehensive review of the aerosol technology literature by separating the text into 3 separate sections. The first section has 7 chapters and evaluates the physiology of aerosol therapy. The second section focuses on the use of aerosol technology in speci!c lung diseases, with 16 chapters focusing on topics including neonatal and pediatric inhalational drug delivery, asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and a chapter exploring nasal drug delivery. The third section is composed of 4 chapters and focuses on integrating strategies, leveraging the information gained from the first 2 sections, exploring such topics as factors affecting lung deposition and future developments in inhalational therapy. This book is extremely well written and referenced with a very logical and concise approach to rich literature, and is a a great resource for clinicians and academicians with an interest in optimizing inhalational therapy. John J. Oppenheimer, MD, FACAAI University of Medicine and Dentistry of New Jersey Newark, New Jersey
Author Information
Hickey, Anthony J. | Mansour, Heidi M.
